B Dubois, J López-Arrieta, S Lipschitz, T Doskas… - Alzheimer's Research & …, 2023 - Springer
Background Masitinib is an orally administered tyrosine kinase inhibitor that targets
activated cells of the neuroimmune system (mast cells and microglia). Study AB09004 …